Julie HENRIQUES is a research engineer in biostatistics. She passed in 2010 a master’s degree in statistical modeling at the University of Franche-Comté. During the master’s degree’s internship in the biostatistics service of the Hospices Civils of Lyon, she realized a study on the correction of survival estimates in the context of loss to follow-up in HIV cohort . She worked as independent statistician for 5 years and participated to projects in many area such as financial times series, reservoir computing or EEG signal processing.
In 2015, she joined the Methodology and quality of life unit in Oncology (UMQVC) at the University hospital of Besancon.
Latest publications
AbstractIntroduction: Regorafenib (R) and trifluridine/tipiracil (FTD/TPI) are of proven efficacy in metastatic...
Posted by : Mme. Julie HENRIQUES, Dr. Dewi VERNEREY
Journal name : Clinical colorectal cancer
AbstractPurpose: The aim of this study was to investigate the association between expression of insulin-like growth...
Posted by : Mme. Julie HENRIQUES
Journal name : Cell Oncol (Dordr)
AbstractBackground: To evaluate the objective response rate (ORR) at 2 months of treatment with regorafenib...
Posted by : Mme. Julie HENRIQUES
Journal name : Cancer Imaging
AbstractBackground: Patients with RAS wild-type (WT) nonresectable metastatic colorectal cancer (mCRC) may receive...
Posted by : Mme. Julie HENRIQUES, Dr. Dewi VERNEREY
Journal name : Oncologist
AbstractBackground: In 2013, the interim analysis of the Protocol for Herceptin as Adjuvant therapy with Reduced...
Posted by : Dr. Sophie PAGET-BAILLY, Mme. Julie HENRIQUES
Journal name : Lancet
AbstractBackground: Failed kidney transplant is becoming a frequent cause of dialysis initiation. Although studies...
Posted by : Mme. Julie HENRIQUES, Dr. Dewi VERNEREY
Journal name : Nephrol Dial Transplant
AbstractBackground: The use of absorbable meshes during contaminated or infected incisional hernia (IH) repair is...
Posted by : Mme. Julie HENRIQUES
Journal name : J Gastrointest Surg
AbstractObjective: To evaluate the effects of switching from prednisone (P) to dexamethasone (D) at asymptomatic...
Posted by : Mme. Julie HENRIQUES, Pr. Franck BONNETAIN
Journal name : BJU Int
AbstractHigh-risk HPV (hrHPV) testing has been implemented as a primary screening tool for cervical cancer in numerous...
Posted by : Dr. Sophie PAGET-BAILLY, Dr. Dewi VERNEREY, Mme. Aurélia MEURISSE, Mme. Julie HENRIQUES
Journal name : Cancers (Basel)
AbstractBackground: Small bowel adenocarcinoma is a rare cancer, and the role of adjuvant chemotherapy for...
Posted by : Mme. Julie HENRIQUES, Dr. Dewi VERNEREY
Journal name : JNCI Cancer Spectr.